Regional Cancer Centre

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Diffuse large B-cell lymphoma1 trial
• Multiple myeloma1 trial
• Myeloproliferative neoplasms1 trial

Phase

• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• Johnson & Johnson Private Limited1 trial
• Karyopharm Therapeutics Inc1 trial
• Takeda1 trial

Running trials

• Recruiting

  A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  NCT07623161· Phase 3· Takeda· Source

  Contact: Sungeeth Thambi (principal investigator)

• Active, not recruiting

  A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

  NCT07030517· Phase 4· Johnson & Johnson Private Limited· Source

• Active, not recruiting

  Selinexor (KPT-330) in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

  NCT02227251· Phase 2· Karyopharm Therapeutics Inc· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myeloproliferative neoplasms1 recruiting